Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H H van Boven

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Seminars in Hematology|July 1, 1997
Antithrombin and its inherited deficiency statesH H van Boven, D A Lane
Blood|October 9, 1999
Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiencyH H van Boven, J P Vandenbroucke, E Briët, et al.
Lancet (London, England)|October 24, 1992
Lover's armT Koster, H H van Boven, S S van Boom, et al.
Thrombosis and Haemostasis|March 1, 1997
Mortality and causes of death in inherited antithrombin deficiencyH H van Boven, J P Vandenbroucke, R G Westendorp, et al.
Familial Cancer|July 16, 2017
Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overviewS Farag, L E van der Kolk, H H van Boven, et al.
Blood|December 15, 1994
Hereditary antithrombin deficiency: heterogeneity of the molecular basis and mortality in Dutch familiesH H van Boven, R J Olds, S L Thein, et al.
Thrombosis and Haemostasis|March 1, 1996
Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiencyH H van Boven, P H Reitsma, F R Rosendaal, et al.
Gynecologic Oncology|December 13, 2016
Risk of cervical intra-epithelial neoplasia and invasive cancer of the cervix in DES daughtersJ Verloop, F E van Leeuwen, Th J M Helmerhorst, et al.
British Journal of Cancer|April 12, 2007
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up studyB B J Hermsen, R I Olivier, R H M Verheijen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Seminars in Hematology|July 1, 1997
Antithrombin and its inherited deficiency statesH H van Boven, D A Lane
Blood|October 9, 1999
Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiencyH H van Boven, J P Vandenbroucke, E Briët, et al.
Lancet (London, England)|October 24, 1992
Lover's armT Koster, H H van Boven, S S van Boom, et al.
Thrombosis and Haemostasis|March 1, 1997
Mortality and causes of death in inherited antithrombin deficiencyH H van Boven, J P Vandenbroucke, R G Westendorp, et al.
Familial Cancer|July 16, 2017
Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overviewS Farag, L E van der Kolk, H H van Boven, et al.
Blood|December 15, 1994
Hereditary antithrombin deficiency: heterogeneity of the molecular basis and mortality in Dutch familiesH H van Boven, R J Olds, S L Thein, et al.
Thrombosis and Haemostasis|March 1, 1996
Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiencyH H van Boven, P H Reitsma, F R Rosendaal, et al.
Gynecologic Oncology|December 13, 2016
Risk of cervical intra-epithelial neoplasia and invasive cancer of the cervix in DES daughtersJ Verloop, F E van Leeuwen, Th J M Helmerhorst, et al.
British Journal of Cancer|April 12, 2007
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up studyB B J Hermsen, R I Olivier, R H M Verheijen, et al.
Pageof 1